SCHEMBL7323585

SCHEMBL7323585

N#Cc1ccccc1NC(=O)c1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ORAI1 Q96D31 3/20 0.60
TP53 P04637 2/20 0.50
THRB P10828 1/20 0.49
MAPT P10636 3/20 0.48
TRPC3 Q13507 2/20 0.46
TRPC1 P48995 1/20 0.46
STIM1 Q13586 1/20 0.46
CRACR2A Q9BSW2 2/20 0.46
TRPC5 Q9UL62 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KMT2A Q03164 2/20 0.45
EPHX2 P34913 3/20 0.45
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7324206 0.84 ORAI1 (0.63) ORAI1TP53THRBMAPTTRPC3
SCHEMBL7318849 0.84 ORAI1 (0.69) ORAI1TP53THRBMAPTTRPC3
SCHEMBL7316907 0.82 ORAI1 (0.61) ORAI1TP53THRBMAPTTRPC3
SCHEMBL7326377 0.81 ORAI1 (0.74) ORAI1TP53THRBMAPTTRPC3
SCHEMBL7318446 0.81 ORAI1 (0.74) ORAI1TP53THRBMAPTTRPC3
SCHEMBL7319850 0.80 ORAI1 (0.64) ORAI1TP53THRBMAPTTRPC3
SCHEMBL7316344 0.80 ORAI1 (0.59) ORAI1TP53THRBMAPTTRPC3
SCHEMBL7320557 0.79 ORAI1 (0.79) ORAI1TP53THRBMAPTTRPC3
SCHEMBL3475644 0.78 RXRA (0.50) TP53MAPTNPC1RAB9AKMT2A
SCHEMBL7316211 0.78 ORAI1 (0.63) ORAI1TP53THRBMAPTTRPC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 ORAI1 3522/4885TP53 1903/4885THRB 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.